A recent study analyzing cancer-specific splicing in more than 1,000 patients identified a non-canonical ADGRF5/GPR116 isoform with an altered C terminus representing an alternative spliced ADGRF5/GPR116 variant (Fig. 1). This evidence concerns the gene ADGRF5 and cancer.